Page last updated: 2024-09-03

2-(2,3-dicarboxycyclopropyl)glycine and bucladesine

2-(2,3-dicarboxycyclopropyl)glycine has been researched along with bucladesine in 1 studies

Compound Research Comparison

Studies
(2-(2,3-dicarboxycyclopropyl)glycine)
Trials
(2-(2,3-dicarboxycyclopropyl)glycine)
Recent Studies (post-2010)
(2-(2,3-dicarboxycyclopropyl)glycine)
Studies
(bucladesine)
Trials
(bucladesine)
Recent Studies (post-2010) (bucladesine)
1660279,77513210

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buisson, A; Choi, DW; Yu, SP1

Other Studies

1 other study(ies) available for 2-(2,3-dicarboxycyclopropyl)glycine and bucladesine

ArticleYear
DCG-IV selectively attenuates rapidly triggered NMDA-induced neurotoxicity in cortical neurons.
    The European journal of neuroscience, 1996, Volume: 8, Issue:1

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Bucladesine; Cell Death; Cell Survival; Cells, Cultured; Cerebral Cortex; Cyclic AMP; Cyclopropanes; Glycine; Kainic Acid; Membrane Potentials; Mice; N-Methylaspartate; Neurons; Neurotoxins; Pertussis Toxin; Receptors, Metabotropic Glutamate; Virulence Factors, Bordetella

1996